Related Experiment Video
Updated: May 26, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
Published on: July 16, 2012
Hepatitis C virus evasion mechanisms from neutralizing antibodies
Caterina Di Lorenzo1, Allan G N Angus1, Arvind H Patel1
1MRC - University of Glasgow Centre for Virus Research, Church Street, Glasgow, G11 5JR, UK.
Insights
Hepatitis C virus (HCV) evades immune responses by developing mechanisms to escape neutralizing antibodies. Understanding these viral evasion strategies is crucial for developing new treatments and vaccines for chronic HCV infection.
Area of Science:
- Virology
- Immunology
- Hepatology
Background:
- Hepatitis C virus (HCV) infection is a global health concern, leading to chronic hepatitis, cirrhosis, and liver cancer.
- Current therapies for HCV are limited by resistance, side effects, and cost, with no available vaccine.
- While cell-mediated immunity is vital for viral clearance, the role of host antibodies in HCV infection is gaining recognition.
Purpose of the Study:
- To review the current understanding of mechanisms employed by HCV to evade host neutralizing antibodies.
- To highlight the importance of studying viral immune evasion for designing novel preventive and therapeutic strategies.
Main Methods:
- This review synthesizes existing research on HCV immune evasion.
- Analysis of studies investigating the induction and efficacy of neutralizing antibodies in acute and chronic HCV infections.
Main Results:
- Individuals who clear HCV infection develop early neutralizing antibodies.
- Patients with chronic HCV infection develop high titers of neutralizing antibodies, which are ineffective in controlling the virus.
- HCV employs specific mechanisms to evade immune surveillance by host neutralizing antibodies.
Conclusions:
- HCV has evolved sophisticated strategies to escape neutralization by host antibodies, contributing to persistent infections.
- A deeper understanding of HCV's immune evasion tactics is essential for the development of effective vaccines and therapies.
- Targeting viral evasion mechanisms could offer new avenues for controlling Hepatitis C virus.
Abstract:
Hepatitis C virus (HCV) represents a major public health problem, affecting 3% of the world's population. The majority of infected individuals develop chronic hepatitis, which can progress to cirrhosis and hepatocellular carcinoma. To date, a vaccine is not available and current therapy is limited by resistance, adverse effects and high costs. Although it is very well established that cell-mediated immunity is necessary for viral clearance, the importance of host antibodies in clearing HCV infection is being increasingly recognized. Indeed, recent studies indicate that neutralizing antibodies are induced in the early phase of infection by patients who subsequently clear viral infection. Conversely, patients who do not clear the virus develop high titers of neutralizing antibodies during the chronic stage. Surprisingly, these antibodies are not able to control HCV infection. HCV has therefore developed mechanisms to evade immune elimination, allowing it to persist in the majority of infected individuals. A detailed understanding of the mechanisms by which the virus escapes immune surveillance is therefore necessary if novel preventive and therapeutic treatments have to be designed. This review summarizes the current knowledge of the mechanisms used by HCV to evade host neutralizing antibodies.
Related Concept Videos
Hepatitis
Viruses with RNA Genomes
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Inhibitors of Viral Protein Synthesis

